WO2007060380A1 - Process for the manufacture of iohexol - Google Patents

Process for the manufacture of iohexol Download PDF

Info

Publication number
WO2007060380A1
WO2007060380A1 PCT/GB2006/000768 GB2006000768W WO2007060380A1 WO 2007060380 A1 WO2007060380 A1 WO 2007060380A1 GB 2006000768 W GB2006000768 W GB 2006000768W WO 2007060380 A1 WO2007060380 A1 WO 2007060380A1
Authority
WO
WIPO (PCT)
Prior art keywords
process according
solvent
iohexol
dihydroxypropyl
acetamido
Prior art date
Application number
PCT/GB2006/000768
Other languages
French (fr)
Inventor
José Galindro
Susana Marto
João António Moínho BANDARRA
William Heggie
Original Assignee
Hovione Inter Ltd
Turner, Craig, Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12/094,589 priority Critical patent/US7541494B2/en
Priority to JP2008541802A priority patent/JP5139993B2/en
Priority to EP06709991A priority patent/EP1951657B1/en
Priority to AU2006318924A priority patent/AU2006318924B2/en
Priority to PL06709991T priority patent/PL1951657T3/en
Priority to CN200680051705XA priority patent/CN101336228B/en
Application filed by Hovione Inter Ltd, Turner, Craig, Robert filed Critical Hovione Inter Ltd
Priority to AT06709991T priority patent/ATE529396T1/en
Priority to BRPI0620543-7A priority patent/BRPI0620543A2/en
Priority to ES06709991T priority patent/ES2375494T3/en
Priority to KR1020087015202A priority patent/KR101320436B1/en
Publication of WO2007060380A1 publication Critical patent/WO2007060380A1/en
Priority to NO20082271A priority patent/NO340888B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/08Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/69Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton

Definitions

  • the present invention is related to a process for the manufacture of iohexol, 5-[N-(2,3-dihydroxypropyl)-acetamido]-N I N'-bis(2 ) 3-dihydroxypropyl)2,4,6- triiodoisophtalamide.
  • Iohexol is one of the most often used non-ionic iodinated X-ray contrast agents. In the manufacture of iohexol a multi-step synthesis is involved.
  • crude iohexol is isolated by removal of the high boiling solvent such as 2- methoxyethanol, usually by distillation, followed by purifying the crude product by known methods and finally, crystallizing from a suitable alcohol as described in US-6,469,208 and references cited therein, or from mixtures of solvents including the high boiling reaction solvents and alcohols such as methanol as disclosed in WO2005/003080 or 1-methoxy-2-propanol either alone or mixed with other solvents such as isopropanol as claimed in US-6,897,339.
  • the high boiling solvent such as 2- methoxyethanol
  • the present invention provides a process for the production of iohexol which process comprises alkylating 5-Acetamido-N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodoisophthalamide using 2(2-methoxy-ethoxy)- ethanol as solvent in the presence of a base, and optionally isolating crude iohexol from the reaction mixture.
  • the crude iohexol is filtered, washed with the non-solvent to remove the remaining of the reaction solvent and other impurities from the reaction.
  • An added advantage is that the yield of recovered iohexol is almost quantitative. Thereafter, the filter cake is dissolved in water and the salts formed during the reaction are removed by the use of ion exchange resins. After further purification, if necessary, the water is removed and the iohexol can be crystallized from ethanol using the conditions disclosed in US-6,469,208.
  • 2-(2- methoxyethoxy)ethanol is an excellent solvent for basified 5-acetamido-N,N J -bis(2,3-dihydroxypropyl)-2 ! 4,6-triiodoisophthalamide, dissolution is achieved after one to two hours of stirring in the conditions described hereafter.
  • the method of the present invention reduces the time that 5- acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is in contact with base at high temperatures before the addition of the alkylation agent, thus reducing the potential formation of impurities.
  • the 5-acetamido-N,N'- bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is stirred at 45 0 C overnight. This prolonged initial phase of the reaction implies longer processing times.
  • the process of the present invention requires much shorter times and the typical end point for complete reaction at which time the reaction is quenched takes less than 24 hours. This results in a reduction of the impurities resulting from O-alkylation reactions and other miscellaneous process impurities.
  • 5-acetamido-N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodoisophthalamide is allowed to react with an alkylating agent, which is preferably 3-chioropropane-1 ,2-diol, in 2-(2- methoxyethoxy)ethanol (the reaction solvent) preferably at a concentration of 25% to 40% (w/w) relative to the solvent, suitably at 25 0 C to 33 0 C for preferably 18 to 24 hours.
  • an alkylating agent which is preferably 3-chioropropane-1 ,2-diol
  • 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide is suspended in 2-(2-methoxyethoxy)ethanol and a base, which is preferably a concentrated aqueous solution of an alkali metal hydroxide, more preferably sodium hydroxide, suitably at a temperature of from 40 to 6O 0 C, preferably from 50 to 55 0 C, is added to cause dissolution.
  • the concentration of the base for example, sodium hydroxide solution, is preferably between 59 to 73% weight/volume of water, more preferably between 65 to 67%. Dissolution is typically achieved after about one to two hours of stirring at temperatures between 40 to 60 0 C.
  • the alkylating agent for example 3-chloropropane-1 ,2-diol
  • the reaction is allowed to proceed, suitably at a temperature of from 25 to 35 0 C, preferably from 29 to 31 0 C until the desired level of conversion is achieved.
  • the suspension is cooled preferably for not less than one hour to a temperature of from O 0 C to 25 0 C, preferably at a temperature of from 0 to 5 0 C and typically stirred for not less than half an hour with the objective of maximize the yield.
  • the solids are separated by filtration and washed with the non-solvent, which can be previously cooled before this wash.
  • Another important advantage of the present invention is that the non- solvent can be recovered from the mother liquor, as it is easily separated from the higher boiling 2-(2-methoxyethoxy)ethanol by simple distillation, and reutilized in the process, thus diminishing environmental impact by reduction of the volume of organic waste and reducing industrial costs.
  • the crude iohexol can be further purified by the methods described in the prior art, for example in US-6,469,208.
  • the process of the invention is best clarified by the description of the non-limiting examples described hereafter.
  • reaction mixture was heated to 60 to 7O 0 C and 12ml of solvent were distilled under vacuum.
  • the water content after distillation was 0 0.16% (w/w).
  • the warm iohexol solution in 2-(2-methoxy-ethoxy)ethanol was slowly added to 400 ml of acetone previously heated to a temperature between 5O 0 C to 55 0 C at stirred during 30 minutes at the same temperature.
  • the suspension was cooled to a temperature between O 0 C to 5 0 C, filtered under nitrogen and the solid suspended in acetone (200 ml) after which it was stored 5 overnight at room temperature.
  • the suspension was cooled to a temperature between O 0 C to 5 0 C and stirred during 30 minutes at this temperature.
  • Example 5 A solution of crude iohexol (15% w/w) in water, containing 88.26g of iohexol was sequentially passed through a set of acid and basic ion exchange resins to remove the salts and other process impurities. The water was removed by distillation and the solvent replaced by ethanol. The water content was further reduced by azeotropic distillation and the iohexol then crystallized from ethanol (354ml) at 75 0 C with a water content below 1 % w/w in the crystallization mixture.
  • Example 6 A solution of crude iohexol (11 % w/w) in water, containing 35.75g of iohexol (previously separated from the reaction mixture by precipitation with propan-2-ol and dried in the conditions example 2) was sequentially passed through a set of acid and basic ion exchange resins to remove the salts and other process impurities, iohexol was isolated in the experimental conditions described in Example 5. The water was removed by distillation and the solvent replaced by ethanol. The water content was further reduced by azeotropic distillation and the iohexol finally crystallized from ethanol (200ml) at 75 0 C with a water content below 1 % w/w in the crystallization mixture.
  • the iohexol so obtained was washed with ethanol (185ml) at 75 0 C and stirred for 4 hours at this temperature, the suspension was cooled to below 5 0 C, filtered and washed with absolute ethanol (50ml). After drying at 6O 0 C, 22.37g of iohexol was obtained with purity by HPLC of 99.6% in area with 0.22% of O-alkylation impurities. The content by HPLC of the largest single unknown impurity present in the final product is 0.03% and the content of 2-(2-methoxy-ethoxy)ethanol 51 ppm.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A process for the production of iohexol comprises alkylating 5-Acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide using 2(2-methoxy-ethoxy)-ethanol as solvent in the presence of a base, and optionally isolating crude iohexol from the reaction mixture. Preferably, the alkylating agent is 1-chloro-2,3 propanediol and the base is an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide.

Description

PROCESS FOR THE MANUFACTURE OF IOHEXOL
The present invention is related to a process for the manufacture of iohexol, 5-[N-(2,3-dihydroxypropyl)-acetamido]-NIN'-bis(2)3-dihydroxypropyl)2,4,6- triiodoisophtalamide.
Iohexol is one of the most often used non-ionic iodinated X-ray contrast agents. In the manufacture of iohexol a multi-step synthesis is involved.
Several methods have been disclosed in the literature for the synthesis of iohexol. Given that the dose of iohexol, which is administered over a short period of time, can be up to, or even more than 100g the use of solvents with low toxicity in the last step is crucial as it is to be expected that some residual solvent, even at low levels, always remains in the final product. From an industrial point of view both easily available and solvents of low toxicity are preferable when carrying out the last step of the process. An efficient and industrially viable purification and crystallization step is required not only to obtain a product wherein the impurities are kept at minimal levels but also where the levels of residual solvents is also very low. The use of 2- methoxyethanol and mixtures of 2-methoxyethanol / isopropanol and a solvent chosen from a C1-C5-monoalkylether of a C3-C10 alkylene-glycol are respectively disclosed in WO 98/08804 and WO 2005/003080 as reaction solvents in which the N-alkylation of the nitrogen atom of 5-acetamido-N,N'- bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is carried out.
According to procedures defined in the prior art, after complete reaction, crude iohexol is isolated by removal of the high boiling solvent such as 2- methoxyethanol, usually by distillation, followed by purifying the crude product by known methods and finally, crystallizing from a suitable alcohol as described in US-6,469,208 and references cited therein, or from mixtures of solvents including the high boiling reaction solvents and alcohols such as methanol as disclosed in WO2005/003080 or 1-methoxy-2-propanol either alone or mixed with other solvents such as isopropanol as claimed in US-6,897,339.
Industrially, the removal of high boiling solvents is a time and energy consuming operation. There is also an increased risk that the product will degrade if high temperatures are involved during this concentration step. In addition, from an environmental point of view, both the aqueous and organic streams of the process have to be disposed-of, increasing costs considerably.
The use of a more convenient solvent in the reaction step, which is easily eliminated, and which allows crude iohexol to be isolated in a simple fashion, preferably by precipitation of the reaction mixture with a non-solvent that is easily removable by a subsequent treatment is to be preferred. According to the procedure of the present invention, the crude iohexol is isolated by precipitation. The remainder of the process steps, up to the final crystallization are essentially aqueous, which is both industrially and environmental more desirable. A further advantage is that the overall cost of the manufacturing process is reduced.
Having appreciated the above needs, we have now found that, surprisingly, 2-(2-methoxyethoxy)ethanol meets the requirements as outlined above.
Accordingly, the present invention provides a process for the production of iohexol which process comprises alkylating 5-Acetamido-N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodoisophthalamide using 2(2-methoxy-ethoxy)- ethanol as solvent in the presence of a base, and optionally isolating crude iohexol from the reaction mixture.
When 2-(2-methoxyethoxy)ethanol is used in conjunction with a lower boiling non-solvent such as acetone, 4-methylpentan-2-one, 2-methylpropan-1- ol, propan-2-ol or isopropyl acetate in the isolation step, the crude iohexol can be precipitated directly from the reaction mixture. The 2-(2- methoxyethoxy)ethanol, can then be efficiently removed from the solid by filtration followed by washing of the filter cake with the low boiling solvent chosen. The solvents known in the prior art such as the structurally similar 2- methoxyethanol cannot be used in this procedure due to the formation of gummy solids. Thus the crude iohexol is filtered, washed with the non-solvent to remove the remaining of the reaction solvent and other impurities from the reaction. An added advantage is that the yield of recovered iohexol is almost quantitative. Thereafter, the filter cake is dissolved in water and the salts formed during the reaction are removed by the use of ion exchange resins. After further purification, if necessary, the water is removed and the iohexol can be crystallized from ethanol using the conditions disclosed in US-6,469,208.
A further unexpected advantage that the use of 2-(2- methoxyethoxy)ethanol bestows on the process is that it is surprisingly highly efficient as reaction solvent for the production of iohexol. Some of the benefits are: the reaction can be carried out at high concentration; the reaction can be carried out at lower temperatures thus reducing decomposition and formation of by-products; less solvent is necessary and therefore waste streams are significantly reduced. 2-(2-Methoxyethoxy)ethanol is an excellent solvent for basified 5-acetamido-N,NJ-bis(2,3-dihydroxypropyl)-2!4,6-triiodoisophthalamide, dissolution is achieved after one to two hours of stirring in the conditions described hereafter. This is an important improvement over the prior art because the method of the present invention reduces the time that 5- acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is in contact with base at high temperatures before the addition of the alkylation agent, thus reducing the potential formation of impurities. Typically, in the prior art (see the examples described in WO 2005/003080), the 5-acetamido-N,N'- bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide is stirred at 450C overnight. This prolonged initial phase of the reaction implies longer processing times. The process of the present invention requires much shorter times and the typical end point for complete reaction at which time the reaction is quenched takes less than 24 hours. This results in a reduction of the impurities resulting from O-alkylation reactions and other miscellaneous process impurities. In the process of the present invention, 5-acetamido-N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodoisophthalamide is allowed to react with an alkylating agent, which is preferably 3-chioropropane-1 ,2-diol, in 2-(2- methoxyethoxy)ethanol (the reaction solvent) preferably at a concentration of 25% to 40% (w/w) relative to the solvent, suitably at 250C to 330C for preferably 18 to 24 hours. Hence, 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide is suspended in 2-(2-methoxyethoxy)ethanol and a base, which is preferably a concentrated aqueous solution of an alkali metal hydroxide, more preferably sodium hydroxide, suitably at a temperature of from 40 to 6O0C, preferably from 50 to 550C, is added to cause dissolution. The concentration of the base, for example, sodium hydroxide solution, is preferably between 59 to 73% weight/volume of water, more preferably between 65 to 67%. Dissolution is typically achieved after about one to two hours of stirring at temperatures between 40 to 600C. After preferably cooling to a temperature of from 25 to 350C the alkylating agent, for example 3-chloropropane-1 ,2-diol, is added and the reaction is allowed to proceed, suitably at a temperature of from 25 to 350C, preferably from 29 to 310C until the desired level of conversion is achieved.
After complete reaction the pH of the mixture is typically adjusted to below 7, preferably 5 to 6 by the addition a suitable acid, for example hydrochloric acid or acetic acid, and preferably the water content reduced to below 1% (w/w) by vacuum or azeotropic distillation of a small portion of the solvent. The remainder of the solvent is preferably separated from the iohexol by precipitation of the product as a solid in the following way: the mixture is added to warmed non-solvent, for example acetone, at a temperature of from 45 to 6O0C, preferably 52 to 560C. The iohexol precipitates giving a good dispersion of the solids in the mixture. The suspension is cooled preferably for not less than one hour to a temperature of from O0C to 250C, preferably at a temperature of from 0 to 50C and typically stirred for not less than half an hour with the objective of maximize the yield. The solids are separated by filtration and washed with the non-solvent, which can be previously cooled before this wash. Another important advantage of the present invention is that the non- solvent can be recovered from the mother liquor, as it is easily separated from the higher boiling 2-(2-methoxyethoxy)ethanol by simple distillation, and reutilized in the process, thus diminishing environmental impact by reduction of the volume of organic waste and reducing industrial costs. Thereafter, the crude iohexol can be further purified by the methods described in the prior art, for example in US-6,469,208. The process of the invention is best clarified by the description of the non-limiting examples described hereafter.
Example 1
5 5-Acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophtalamide
(20Og; 0.27 moles) was added to 2-(2-methoxy-ethoxy)ethanol (300 ml) and heated to 44-460C. At this temperature a previously prepared solution of sodium hydroxide (15.0 g) and water (18.3 ml) was added and the mixture was heated to 50-520C until dissolution. The solution was cooled to 29°C-31°C and
10 1-chloro-2,3-propanodiol (37.2 g) was added to the solution. The temperature was set at 29-31 0C and stirred until complete reaction (21 h). Quenching was carried out by the addition of concentrated hydrochloric acid until a pH between 4 to 5. Part of the solvent was distilled under vacuum until a value of water content by Karl-Fischer of 0.04% w/w in the reaction mixture.
15 The solution was slowly added to acetone (1600 ml) previously heated to
550C. The suspension was cooled to a temperature between O0C to 50C, filtered under nitrogen and the solid suspended into acetone (800 ml) at O0C, filtered under nitrogen, washed with acetone (200 ml) and dried at 60 0C. 236.6g of crude iohexol were obtained with a content of 2-(2-methoxy-
20 ethoxy)ethanol of 2547ppm.
Example 2
5-Acetamido-NIN'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophtalamide (100g) was added to 2-(2-methoxy-ethoxy)ethanol (125 ml) and heated to 44-
25 460C. At this temperature a previously prepared solution of sodium hydroxide (7.48 g) and water (9.12 ml) was added and the mixture was heated to 50-520C until dissolution. 25ml of 2-(2-methoxy-ethoxy)ethanol were used to wash the equipment used to prepare the sodium hydroxide solution and added to the reaction mixture. After about one hour at 520C the reaction mixture was heated
30 to 6O0C and held at this temperature for 20 minutes after which dissolution was observed. The solution was cooled to 29°C-31°C and 1-chloro-2,3-propanodiol (18.8 g) was added to the reaction mixture. The temperature was set at 29-31 0C and stirred until complete reaction (21 h). Quenching was carried out by the addition of 1.72ml of concentrated hydrochloric acid. Part of the solvent was distilled under vacuum until a value of water content by Karl-Fischer of 0.04% w/w in the reaction mixture.
5 The solution was slowly added to 800 ml of recovered acetone previously heated to 560C. The suspension was cooled to a temperature between O0C to 50C, stirred during 1 hour at this temperature, filtered under nitrogen and the solid suspended into recovered acetone (400 ml) at O0C, filtered under nitrogen, washed with acetone (100 ml) and dried at 60 0C. 10 113.4g of crude iohexol were obtained with a content of 2-(2-methoxy- ethoxy)ethanol of 3569ppm.
Example 3
100g of 5-Acetamido-N,N'~bis(2,3-dihydroxypropyl)-2,4,6-
15 triiodoisophtalamide where converted to iohexol in the experimental conditions described in example 2. After complete conversion the reaction was quenched by the addition of 0.8ml of glacial acetic acid.
One half of the reaction mixture was heated to 60 to 7O0C and 12ml of solvent were distilled under vacuum. The water content after distillation was 0 0.16% (w/w). The warm iohexol solution in 2-(2-methoxy-ethoxy)ethanol was slowly added to 400 ml of acetone previously heated to a temperature between 5O0C to 550C at stirred during 30 minutes at the same temperature. The suspension was cooled to a temperature between O0C to 50C, filtered under nitrogen and the solid suspended in acetone (200 ml) after which it was stored 5 overnight at room temperature. The suspension was cooled to a temperature between O0C to 50C and stirred during 30 minutes at this temperature. The solids where collected by filtration, washed with acetone (124 ml) and dried at 60 0C. 56.16g of crude iohexol were obtained with a content of 2-(2-methoxy- ethoxy)ethano! of 6215ppm. 0 Example 4
The water content of a crude iohexol solution corresponding to 25g of 5- Acetamido-N,N'-bis(2,3-dihydroxypropyI)-2,4,6-triiodoisophtalamide (previously converted to crude iohexol in the conditions described in example 2, wherein the solvent was used in a ratio of 3ml per gram of starting 5-acetamido-N,N'- bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) was reduced to not more than 0.4% by azeotropic distillation. After, the reaction mixture was added to 2- methylpropan-1-ol (200ml) previously heated to 750C. The obtained suspension was cooled to room temperature. The solids where collected by filtration, washed with 2-methylpropan-1-ol (75 ml) and dried at 60 0C. 23.45g of crude iohexol were obtained with a content of 2-(2-methoxy-ethoxy)ethanol of 2675ppm.
Example 5 A solution of crude iohexol (15% w/w) in water, containing 88.26g of iohexol was sequentially passed through a set of acid and basic ion exchange resins to remove the salts and other process impurities. The water was removed by distillation and the solvent replaced by ethanol. The water content was further reduced by azeotropic distillation and the iohexol then crystallized from ethanol (354ml) at 750C with a water content below 1 % w/w in the crystallization mixture. The iohexol so obtained was washed with ethanol (268ml) at 750C stirred for 2 hours at this temperature, the suspension was cooled to below 50C, filtered and washed with absolute ethanol. After drying at 6O0C 62.38g of iohexol was obtained with purity by HPLC of 99.2% in area with 0.4% of O-alkylation impurities. The content by HPLC of the largest single unknown impurity present in the final product is 0.03% and the content of 2-(2- methoxy-ethoxy)ethanol 77ppm.
Example 6 A solution of crude iohexol (11 % w/w) in water, containing 35.75g of iohexol (previously separated from the reaction mixture by precipitation with propan-2-ol and dried in the conditions example 2) was sequentially passed through a set of acid and basic ion exchange resins to remove the salts and other process impurities, iohexol was isolated in the experimental conditions described in Example 5. The water was removed by distillation and the solvent replaced by ethanol. The water content was further reduced by azeotropic distillation and the iohexol finally crystallized from ethanol (200ml) at 750C with a water content below 1 % w/w in the crystallization mixture. The iohexol so obtained was washed with ethanol (185ml) at 750C and stirred for 4 hours at this temperature, the suspension was cooled to below 50C, filtered and washed with absolute ethanol (50ml). After drying at 6O0C, 22.37g of iohexol was obtained with purity by HPLC of 99.6% in area with 0.22% of O-alkylation impurities. The content by HPLC of the largest single unknown impurity present in the final product is 0.03% and the content of 2-(2-methoxy-ethoxy)ethanol 51 ppm.

Claims

CLAIMS:
1. A process for the production of iohexol which process comprises alkylating
5-Acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodoisophthalamide using 2(2-methoxy-ethoxy)-ethanol as solvent in the presence of a base, and optionally isolating crude iohexol from the reaction mixture.
2. A process according to claim 1 wherein the alkylating agent is 1-chloro- 2,3 propanediol.
3. A process according to claim 1 or 2 wherein the solvent is used in a ratio of from 1 ml to 3ml per gram of 5-acetamido-NJN'-bis(2,3- dihydroxypropyl)-2,4,6-triiodoisophthalamide.
4. A process according to claim 1 , 2 or 3 where the base is an alkali metal hydroxide, such as sodium hydroxide or potassium hydroxide.
5. A process according to any one of claims 1 to 4 wherein an aqueous solution of the base is added to a suspension of 5-acetamido-N,N'- bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide in the solvent.
6. A process according to any one of claims 1 to 5 wherein the concentration of the base is 59 to 73%, expressed as weight per volume.
7. A process according to any one of claims 1 to 6 wherein the quantity of the base added is from 71 mg to 78.5mg per gram of 5-acetamido-N,N'- bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide.
8. A process according to claim 5, 6 or 7 wherein the temperature of the reaction mixture is set at from 40 to 6O0C and stirred until dissolution is achieved.
9. A process according to any one of claims 1 to 8 where the alkylation reaction is carried out at 250C to 350C.
10. A process according to any one of claims 1 to 9 where the pH of the reaction mixture after complete reaction is adjusted to from 5 to 7 with an acid.
11. A process according to claim 10 wherein the acid is hydrochloric acid or acetic acid.
12. A process according to claim 10 or 11 wherein the water content is adjusted to below 1% by vacuum or azeotropic distillation.
13. A process according to any one of claims 1 to 12 further comprising the isolation of crude iohexol by precipitation with a non-solvent.
14. A process according to claim 13 where the said non-solvent comprises acetone, 2-methylpropan-i-ol, or propan-2-ol.
15. A process according to claim 13 or 14 wherein the reaction mixture is added to the non-solvent at a temperature of from 500C to 750C.
16. A process according to claim 13, 14 or 15 wherein crude iohexol is separated from the solvent by filtration and washing with the non-solvent.
17. A process according to claim 13, 14, 15 or 16 further comprising recovering the non-solvent by distillation and re-using it in the process.
PCT/GB2006/000768 2005-11-24 2006-03-03 Process for the manufacture of iohexol WO2007060380A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP2008541802A JP5139993B2 (en) 2005-11-24 2006-03-03 Method for producing iohexol
EP06709991A EP1951657B1 (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol
AU2006318924A AU2006318924B2 (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol
PL06709991T PL1951657T3 (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol
CN200680051705XA CN101336228B (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol
US12/094,589 US7541494B2 (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol
AT06709991T ATE529396T1 (en) 2005-11-24 2006-03-03 METHOD FOR PRODUCING IOHEXOL
BRPI0620543-7A BRPI0620543A2 (en) 2005-11-24 2006-03-03 Process for iohexol production
ES06709991T ES2375494T3 (en) 2005-11-24 2006-03-03 PROCEDURE TO MANUFACTURE IOHEXOL.
KR1020087015202A KR101320436B1 (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol
NO20082271A NO340888B1 (en) 2005-11-24 2008-05-20 Process for the preparation of iohexole

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103391A PT103391B (en) 2005-11-24 2005-11-24 LOHEXOL MANUFACTURING PROCESS
PT103.391 2005-11-24

Publications (1)

Publication Number Publication Date
WO2007060380A1 true WO2007060380A1 (en) 2007-05-31

Family

ID=36087809

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/000768 WO2007060380A1 (en) 2005-11-24 2006-03-03 Process for the manufacture of iohexol

Country Status (14)

Country Link
US (1) US7541494B2 (en)
EP (1) EP1951657B1 (en)
JP (1) JP5139993B2 (en)
KR (1) KR101320436B1 (en)
CN (1) CN101336228B (en)
AT (1) ATE529396T1 (en)
AU (1) AU2006318924B2 (en)
BR (1) BRPI0620543A2 (en)
ES (1) ES2375494T3 (en)
NO (1) NO340888B1 (en)
PL (1) PL1951657T3 (en)
PT (1) PT103391B (en)
WO (1) WO2007060380A1 (en)
ZA (1) ZA200804421B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011041275A1 (en) * 2009-09-30 2011-04-07 Mallinckrodt Inc. Alkylation of triiodo-substituted arylamides in an aqueous mixed solvent system
WO2015133651A1 (en) * 2014-03-04 2015-09-11 Otsuka Pharmaceutical Co., Ltd. Iohexol powder and method of using the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110021821A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As Continuous acetylation process in synthesis of non-ionic x-ray contrast agents
ES2680019T3 (en) * 2010-12-21 2018-09-03 Ge Healthcare As Desalination of a composition comprising a contrast agent
CN107721875A (en) * 2017-11-21 2018-02-23 苏州纳微科技有限公司 A kind of consummate method of Iohexol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250113A (en) * 1976-06-11 1981-02-10 Nyegaard & Co. A/S Chemical compounds
WO1998008804A1 (en) * 1996-08-29 1998-03-05 Nycomed Imaging As Process for iohexol manufacture
WO2005003080A1 (en) * 2003-07-03 2005-01-13 Amersham Health As Process for iohexol manufacture

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5724378A (en) * 1980-07-22 1982-02-08 Dainippon Ink & Chem Inc Preparation of fluorine-containing epoxy compound
JPH07330711A (en) * 1994-06-03 1995-12-19 Yoshitomi Pharmaceut Ind Ltd Manufacture of high purity 4,4'-thiobis(diphenylthiourea)
PT101919B (en) * 1996-09-30 2000-01-31 Hovione Sociedade Quimica Sa A PROCESS FOR THE PURIFICATION OF TOHEXOL
IT1292037B1 (en) * 1997-05-30 1999-01-25 Bracco Spa PROCESS FOR THE PREPARATION OF 5- (ACETYL 62,3-DIIDROXYPROPYL) - AMINO) -N, N'-BIS (2,3-DIIDROXYPROPYL) -2,4,6-TRIIODE-1,3-BENZEN-
GB9725010D0 (en) * 1997-11-26 1998-01-28 Nycomed Imaging As Process
ITMI20010773A1 (en) * 2001-04-11 2002-10-11 Chemi Spa PROCESS FOR THE PRODUCTION OF HIGH PURITY IOEXOLO

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250113A (en) * 1976-06-11 1981-02-10 Nyegaard & Co. A/S Chemical compounds
WO1998008804A1 (en) * 1996-08-29 1998-03-05 Nycomed Imaging As Process for iohexol manufacture
WO2005003080A1 (en) * 2003-07-03 2005-01-13 Amersham Health As Process for iohexol manufacture

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011041275A1 (en) * 2009-09-30 2011-04-07 Mallinckrodt Inc. Alkylation of triiodo-substituted arylamides in an aqueous mixed solvent system
WO2015133651A1 (en) * 2014-03-04 2015-09-11 Otsuka Pharmaceutical Co., Ltd. Iohexol powder and method of using the same
US10350311B2 (en) 2014-03-04 2019-07-16 Otsuka Pharmaceutical Co., Ltd. Iohexol powder and method of using the same
RU2711501C2 (en) * 2014-03-04 2020-01-17 Оцука Фармасьютикал Ко., Лтд. Iohexol powder and method for use thereof

Also Published As

Publication number Publication date
AU2006318924A1 (en) 2007-05-31
JP2009517373A (en) 2009-04-30
ES2375494T3 (en) 2012-03-01
NO340888B1 (en) 2017-07-10
EP1951657B1 (en) 2011-10-19
KR20090004842A (en) 2009-01-12
JP5139993B2 (en) 2013-02-06
US20090048463A1 (en) 2009-02-19
KR101320436B1 (en) 2013-10-23
ATE529396T1 (en) 2011-11-15
BRPI0620543A2 (en) 2011-11-16
CN101336228B (en) 2013-06-12
PT103391B (en) 2008-10-30
PL1951657T3 (en) 2012-03-30
CN101336228A (en) 2008-12-31
EP1951657A1 (en) 2008-08-06
PT103391A (en) 2007-05-31
NO20082271L (en) 2008-08-12
US7541494B2 (en) 2009-06-02
ZA200804421B (en) 2009-03-25
AU2006318924B2 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
JP5988272B2 (en) Oxycodone synthesis and purification process
EP1951657B1 (en) Process for the manufacture of iohexol
EP1377544B1 (en) Purification of 2-nitro-4-methylsulphonylbenzoic acid
JP4933253B2 (en) Method for producing iohexol
SK26499A3 (en) Process for iohexol manufacture
JP4397990B2 (en) Purification method of 3-alkylflavanonol derivatives
WO2010001379A1 (en) A process for preparing atovaquone and associate intermediates
US7476760B2 (en) Purification and production methods of 1-aminocyclopropanecarboxylic acid
JP5869664B2 (en) Process for producing 5-oxo-4-oxa-5-homoadamantan-2-ol
EP2768807B1 (en) Processes for the preparation of 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide and of its precursors
JP3265142B2 (en) Method for producing 4-alkylbenzoic acids
JP4085199B2 (en) Method for producing O, O-dimethyl-O- (p-cyanophenyl) phosphorothioate
JP4840750B2 (en) Method for producing high purity 4,4'-dihydroxydiphenylsulfone
JP4749759B2 (en) Method for producing dihydrobenzopyran compound
KR101521607B1 (en) Process of isolating methyl-4-formylbenzoate and dimethylterephtalate with high yield
JP2006290753A (en) METHOD FOR PRODUCING 2-(10,11-DIHYDRO-10-OXYDIBENZO[b,f]THIEPIN-2-YL)PROPIONIC ACID
JP2002105056A (en) Method for purifying 2-chloro-4-(1-piperidinylmethyl) pyridine
JPH0827071A (en) Production of 4-nitrodiphenyl ether compound
BE489398A (en)
JP2003335725A (en) METHOD FOR PRODUCING p-CUMIC ACID CRYSTAL

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006318924

Country of ref document: AU

Ref document number: 2006709991

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008541802

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 4564/DELNP/2008

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2006318924

Country of ref document: AU

Date of ref document: 20060303

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006318924

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087015202

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200680051705.X

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2006709991

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12094589

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0620543

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080523